MarketCap
Precision BioSciences DTIL
$ 10.24
27.84%
Facebook
X
Telegram
Country |
 USA |
IPO year |
2019 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
12.8 M |
Market Cap[1] |
$ 131 M |
EBITDA (LTM) |
$ -36.6 M |
P/E (LTM) |
31.590909 |
P/S (LTM) |
1.977708 |
EPS (LTM) |
0.22 |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Fulcrum Therapeutics
FULC
|
$ 3.69 | -2.25 % | $ 234 M | Nasdaq Global Market | USA |
 |
Achieve Life Sciences
ACHV
|
$ 6.39 | -8.42 % | $ 279 M | Nasdaq Capital Market | USA |
 |
Seelos Therapeutics
SEEL
|
- | -47.76 % | $ 6.27 M | Nasdaq Capital Market | USA |
 |
Advaxis
ADXS
|
- | -9.65 % | $ 45.9 M | Nasdaq Capital Market | USA |
 |
Sol-Gel Technologies Ltd.
SLGL
|
$ 63.01 | -4.53 % | $ 176 M | Nasdaq Global Select Market |  Israel |
 |
SELLAS Life Sciences Group
SLS
|
$ 7.84 | -14.28 % | $ 855 M | Nasdaq Capital Market | USA |
 |
Syndax Pharmaceuticals
SNDX
|
$ 9.34 | -10.67 % | $ 809 M | Nasdaq Global Select Market | USA |
 |
Galmed Pharmaceuticals Ltd.
GLMD
|
$ 4.63 | 21.05 % | $ 20 M | Nasdaq Capital Market | Israel |
 |
Spero Therapeutics
SPRO
|
$ 1.02 | -4.82 % | $ 57.1 M | Nasdaq Global Select Market | USA |
 |
Kiromic BioPharma
KRBP
|
- | 6.61 % | $ 3.08 M | Nasdaq Global Select Market | USA |
 |
CNS Pharmaceuticals
CNSP
|
$ 4.01 | -7.6 % | $ 1.78 M | Nasdaq Capital Market | USA |
 |
Geron Corporation
GERN
|
$ 0.95 | -11.87 % | $ 633 M | Nasdaq Global Select Market | USA |
 |
Stoke Therapeutics
STOK
|
$ 26.09 | -4.95 % | $ 1.55 B | Nasdaq Global Select Market,SPB | USA |
 |
Calithera Biosciences
CALA
|
- | -10.95 % | $ 876 K | Nasdaq Global Select Market | USA |
 |
Sutro Biopharma
STRO
|
$ 9.16 | -7.8 % | $ 77.8 M | Nasdaq Global Select Market | USA |
 |
China SXT Pharmaceuticals
SXTC
|
$ 2.94 | -1.34 % | $ 2 M | Nasdaq Global Select Market |  China |
 |
Takeda Pharmaceutical Company Limited
TAK
|
$ 21.24 | 0.83 % | $ 33.5 B | NYSE |  Japan |
 |
Protara Therapeutics
TARA
|
$ 2.12 | -9.79 % | $ 90.8 M | Nasdaq Global Market | USA |
 |
Tarsus Pharmaceuticals
TARS
|
$ 67.45 | -2.35 % | $ 2.82 B | Nasdaq Global Select Market | USA |
|
Applied Molecular Transport
AMTI
|
- | - | $ 10.1 M | Nasdaq Global Select Market,SPB | USA |
 |
Bio-Techne Corporation
TECH
|
$ 72.72 | -0.01 % | $ 11.3 B | Nasdaq Global Select Market,SPB | USA |
 |
Teva Pharmaceutical Industries Limited
TEVA
|
$ 41.75 | -0.12 % | $ 47.8 B | NYSE | Israel |
 |
Molecular Templates
MTEM
|
- | -23.43 % | $ 495 K | Nasdaq Capital Market | USA |
 |
Gossamer Bio
GOSS
|
$ 9.54 | -4.12 % | $ 2.18 B | Nasdaq Global Select Market,SPB | USA |
 |
Genmab A/S
GMAB
|
$ 52.76 | -4.28 % | $ 3.41 B | Nasdaq Global Select Market |  Danmark |
 |
GeoVax Labs
GOVX
|
$ 0.16 | -2.44 % | $ 153 K | Nasdaq Global Select Market | USA |
 |
Grifols, S.A.
GRFS
|
$ 8.49 | -1.39 % | $ 5.77 B | Nasdaq Global Select Market |  Spain |
 |
BioXcel Therapeutics
BTAI
|
$ 0.07 | 9.81 % | $ 855 K | Nasdaq Global Select Market,SPB | USA |
 |
GlaxoSmithKline plc
GSK
|
$ 50.38 | -1.51 % | $ 204 B | NYSE |  Britain |
 |
CohBar
CWBR
|
- | -15.44 % | $ 2.2 M | Nasdaq Capital Market | USA |
 |
Tonix Pharmaceuticals Holding Corp.
TNXP
|
$ 4.6 | -9.88 % | $ 39.2 M | Nasdaq Global Select Market | USA |
 |
NeuBase Therapeutics
NBSE
|
- | -1.56 % | $ 12.3 M | Nasdaq Global Select Market | USA |
 |
Deciphera Pharmaceuticals
DCPH
|
- | - | $ 2.18 B | Nasdaq Global Select Market,SPB | USA |
 |
Arena Pharmaceuticals
ARNA
|
- | -6.81 % | $ 3.04 B | Nasdaq Global Select Market,SPB | USA |
 |
Taysha Gene Therapies
TSHA
|
$ 4.09 | -6.31 % | $ 1.31 B | Nasdaq Global Select Market | USA |
 |
Scopus BioPharma
SCPS
|
- | -48.37 % | $ 3.71 M | Nasdaq Global Select Market | USA |
 |
Annovis Bio
ANVS
|
$ 0.64 | -46.19 % | $ 13.2 M | NYSE American | USA |
 |
scPharmaceuticals
SCPH
|
- | - | $ 218 M | Nasdaq Global Select Market | USA |
 |
Entasis Therapeutics Holdings
ETTX
|
- | - | $ 105 M | Nasdaq Global Market | USA |
 |
Athersys
ATHX
|
- | 3.77 % | $ 22.4 M | Nasdaq Capital Market | USA |
 |
Global Blood Therapeutics
GBT
|
- | - | $ 4.62 B | Nasdaq Global Select Market,SPB | USA |
 |
United Therapeutics Corporation
UTHR
|
$ 565.49 | -7.07 % | $ 25.1 B | Nasdaq Global Select Market,SPB | USA |
 |
Inozyme Pharma
INZY
|
- | - | $ 207 M | Nasdaq Global Select Market | USA |
 |
Veracyte
VCYT
|
$ 23.51 | -55.24 % | $ 1.85 B | Nasdaq Global Market,SPB | USA |
 |
Viking Therapeutics
VKTX
|
$ 25.78 | -7.83 % | $ 2.9 B | Nasdaq Capital Market | USA |
 |
Idera Pharmaceuticals
IDRA
|
- | -23.04 % | $ 26.6 M | Nasdaq Global Select Market | USA |
 |
Verrica Pharmaceuticals
VRCA
|
$ 3.08 | -10.85 % | $ 32.8 M | Nasdaq Global Market | USA |
 |
Viridian Therapeutics
VRDN
|
$ 28.53 | -1.81 % | $ 2.91 B | Nasdaq Capital Market | USA |
 |
NanoString Technologies
NSTG
|
- | -37.43 % | $ 5.1 M | Nasdaq Global Select Market | USA |
 |
Humanigen
HGEN
|
- | -81.12 % | $ 4.28 M | Nasdaq Global Select Market | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.